Study of Preventive Treatment With Symbicort or Budicort Turbohaler in Childhood Asthma Return to School Epidemic
Status
Conditions
Treatments
Details and patient eligibility
About
During the second week of September( week 38 of the year)there are recorded data of exacerbation of asthma all over the world, including Israel. A short preventive treatment of 6 weeks may reduce asthma exacerbation in children,reduce primary care and ER visiting and hospitalization.
Full description
During the second week of September( week 38 of the year)there are recorded data of exacerbation of asthma all over the world, including Israel. A short preventive treatment of 6 weeks may reduce asthma exacerbation in children,reduce primary care and ER visiting and hospitalization.
We will study the effectiveness of Budicort or Symbicort turbuhaler as a preventive treatment in children aged 6-18 years.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
age : 6-18 years suffering from asthma asthma exacerbation during 1/9/2009-15/10/2009
Exclusion criteria
any chronic condition that can involve respiratory tract (other than asthma) treated as prevention with ICS or montelukast from July 2010 Treated with oral steroids during the August 2010 asthma exacerbation one week prior study inclusion
Trial design
Primary purpose
Allocation
Interventional model
Masking
225 participants in 3 patient groups
Trial contacts and locations
Loading...
Central trial contact
Avner He Cohen, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal